New Delhi/IBNS: Within hours after Prime Minister Narendra Modi launched the Covid-19 vaccination drive, the resident doctors of Delhi on Saturday preferred to be inoculated with Oxford vaccine, named Covishield in India, over the indigenous Covaxin.
Guwahati/UNI: The Covid-19 vaccination drive started in Assam on Saturday along with other parts of the country.
New Delhi/IBNS: Prime Minister Narendra Modi on Saturday launched the world's biggest Covid-19 vaccination drive in India, which is one of the worst Novel Coronavirus-hit countries.
New Delhi/IBNS: Prime Minister Narendra Modi will launch the pan India rollout of COVID-19 vaccination drive on Jan 16 at 10:30 AM via video conferencing.
New Delhi/IBNS: Prime Minister Narendra Modi is likely to inaugurate the coronavirus vaccination drive virtually on January 16, said media reports.
Hyderabad/IBNS: A day after the Serum Institute of India (SII) rolled out its vaccine against Covid-19, the first batch of India's indigenous remedy Covaxin, made by Bharat Biotech, left Hyderabad for 11 cities on Wednesday morning, media reports said.
New Delhi/IBNS: The Indian government on Tuesday said that no recipient of Covid-19 vaccine gets to choose from the two candidates available in the country for emergency use.
New Delhi/IBNS: The first batches of coronavirus vaccine began rolling out on early Tuesday from the Pune facility of Serum Institute of India with a total of 56.5 lakh doses to be transported during the day by Air India, SpiceJet, GoAir, and IndiGo, said media reports.
Pune/UNI: Three temperature-controlled trucks rolled out of the Serum Institute's gates shortly before 5 am and left for Pune airport, from where the vaccines will be flown to different parts of India.
New Delhi/IBNS: The government has placed an initial order of 11 million doses of Covishield manufactured by Serum Institute of India (SII), media reports said.
New Delhi/UNI: Hours after the Drugs Controller General of India (DGCI) approved Oxford-AstraZeneca COVID-19 vaccine ''Covishield'' for restricted emergency use, Serum Institute of India (SII) CEO Adar Poonawalla announced that the vaccine is ready to roll out in the coming weeks.
New Delhi/IBNS: India registered 18,177 fresh infections in the last 24 hours taking the total Coronavirus cases to 1,03,23,965 on Sunday, the Union Health Ministry data showed.
New Delhi/IBNS: Two Covid-19 vaccine candidates-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-on Sunday received the approval of the Drugs Controller General of India (DCGI) for emergency use in India.
New Delhi/IBNS: Two Covid-19 vaccine candidates in India-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-now awaits the approval of the Drugs Controller General of India (DCGI) for emergency use after they have been cleared by the government-appointed panel.
New Delhi/IBNS: A government-appointed panel of experts on Friday cleared the Oxford COVID-19 vaccine manufactured by the Serum Institute of India, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).